Concourse Financial Group Securities, Inc. Immunic, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q1 2025 May 14, 2025	BUY	$0.94 - $1.3 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$1.0 - $1.61 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$1.08 - $1.95 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.98 - $1.44 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.14 - $1.53 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.97 - $1.6 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.35 - $2.87 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.35 - $2.87 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.33 - $2.51 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.13 - $10.8 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$3.0 - $5.49 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$3.13 - $12.25 $0 - $0
Q1 2022 May 09, 2022	BUY	$9.54 - $14.26 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$7.34 - $10.25 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$8.05 - $13.29 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $0 - $0
Q1 2021 May 13, 2021	BUY	$14.21 - $25.3 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$14.8 - $20.37 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$11.74 - $22.0 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $0 - $0
Q1 2020 May 13, 2020	BUY	$4.22 - $9.8 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$6.4 - $10.23 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$10.0 - $17.01 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$7.88 - $33.2 $0 - $0

Others Institutions Holding IMUX

# of Institutions

Shares Held

40.2M

Call Options Held

1.14M

Put Options Held

130K

Bvf Inc San Francisco, CA

8.9M
Shares

$6.32 Million
0.43% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

7.29M
Shares

$5.18 Million
0.66% of portfolio
Avidity Partners Management LP Dallas, TX

4.45M
Shares

$3.16 Million
1.09% of portfolio
Vanguard Group Inc Valley Forge, PA

3.93M
Shares

$2.79 Million
0.0% of portfolio
Gratus Capital LLC

2.11M
Shares

$1.5 Million
0.1% of portfolio

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $21.7M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account